Venus Concept (NASDAQ:VERO) Trading 1.6% Higher – Should You Buy?

Venus Concept Inc. (NASDAQ:VERO)’s share price shot up 1.6% during mid-day trading on Friday . The stock traded as high as $0.42 and last traded at $0.39. 165,537 shares were traded during mid-day trading, a decline of 64% from the average session volume of 465,373 shares. The stock had previously closed at $0.38.

Venus Concept Stock Up 1.6 %

The company has a market capitalization of $2.80 million, a P/E ratio of -0.05 and a beta of 0.47. The company has a quick ratio of 1.18, a current ratio of 1.86 and a debt-to-equity ratio of 2.83. The firm has a fifty day simple moving average of $0.35 and a 200-day simple moving average of $0.50.

Institutional Investors Weigh In On Venus Concept

A hedge fund recently raised its stake in Venus Concept stock. Masters Capital Management LLC lifted its stake in Venus Concept Inc. (NASDAQ:VERO) by 100.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 666,702 shares of the company’s stock after acquiring an additional 333,366 shares during the quarter. Masters Capital Management LLC owned approximately 10.49% of Venus Concept worth $522,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Venus Concept Company Profile

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.